Biostar Pharmaceuticals, Inc. Receives Approval From Xianyang SFDA To Restart Sales Of Its Gel Capsule Drugs
03:48 EDT 6 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
XIANYANG, China, Aug. 3, 2012 /PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and c...
Other Sources for this Article
More From BioPortfolio on "Biostar Pharmaceuticals, Inc. Receives Approval From Xianyang SFDA To Restart Sales Of Its Gel Capsule Drugs"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
